IRIS
Lorusso, Domenica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 534
NA - Nord America 192
EU - Europa 30
AF - Africa 1
SA - Sud America 1
Totale 758
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 437
US - Stati Uniti d'America 191
CN - Cina 91
CZ - Repubblica Ceca 12
DE - Germania 7
IT - Italia 6
FI - Finlandia 3
ES - Italia 2
HK - Hong Kong 2
IN - India 2
BR - Brasile 1
CA - Canada 1
KR - Corea 1
MM - Myanmar 1
ZA - Sudafrica 1
Totale 758
Salva come PNG Salva come JPEG
Città #
Singapore 311
Shanghai 91
Santa Clara 30
Seattle 29
Boardman 26
Brno 7
Munich 6
Olomouc 5
Turin 4
Helsinki 3
Ahmedabad 2
Hong Kong 2
Naples 2
Pamplona 2
Engelhard 1
Hamm 1
Kensington 1
Miami 1
New York 1
Pretoria 1
Seodaemun-gu 1
São Paulo 1
Totale 528
Salva come PNG Salva come JPEG
Nome #
Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer 19
Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience 14
Sentinel Node Mapping in Endometrial Cancer By Using Hysteroscopic Injection of Indocyanine Green and Laparoscopic Near-Infrared Fluorescence Imaging: A Preliminary Experience 13
Accuracy of pre-operative hysteroscopic guided biopsy for predicting final pathology in uterine malignancies 12
A Treatment Selection Protocol for Recurrent Ovarian Cancer Patients: The Role of FDG-PET/CT and Staging Laparoscopy 11
Do you agree with populations that have been defined as 'noncandidates' to receiving platinum? 9
Celecoxib plus cartioplatin in heavily pre-treated patients with recurrent ovarian carcinoma: Preliminary results of a Phase II study 9
Implementation of Extensive Cytoreduction Resulted in Improved Survival Outcomes for Patients with Newly Diagnosed Advanced-Stage Ovarian, Tubal, and Peritoneal Cancers 9
Phase I study of gemcitabine and liposomal doxorubicin in relapsed ovarian cancer 9
Management of Adverse Events During Rucaparib Treatment for Relapsed Ovarian Cancer: A Review of Published Studies and Practical Guidance 8
Peritoneal cytology as prognostic factor in cervical cancer 8
Advanced ovarian cancer: Omental bursa, lesser omentum, celiac, portal and triad nodes spread as cause of inaccurate evaluation of residual tumor 8
Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience. 8
Bulky mesonephric adenocarcinoma of the uterine cervix treated with neoadjuvant chemotherapy and radical surgery: report of the first case 8
Minimally Invasive Surgical Staging for Ovarian Carcinoma: A Propensity-Matched Comparison With Traditional Open Surgery 8
Lurbinectedin versus pegylated liposomal doxorubicin or topotecan in patients with platinum-resistant ovarian cancer: A multicenter, randomized, controlled, open-label phase 3 study (CORAIL) 7
A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses 7
Management of stage III and IVa uterine cancer 7
Impact of Recurrence of Ovarian Cancer on Quality of Life and Outlook for the Future 7
Regarding "The Role of Routine Peritoneal and Omental Biopsies at Risk-reducing Salpingo-oophorectomy" 7
TERAPIA PRIMARIA DEL CARCINOMA DELL'ENDOMETRIO: CHEMIOTERAPIA 7
Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses 7
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study 6
When Does Neoadjuvant Chemotherapy Really Avoid Radiotherapy? Clinical Predictors of Adjuvant Radiotherapy in Cervical Cancer 6
Carboplatin-Paclitaxel Versus Cisplatin-Ifosfamide in the Treatment of Uterine Carcinosarcoma A Retrospective Cohort Study 6
Preexisting TP53-Variant Clonal Hematopoiesis and Risk of Secondary Myeloid Neoplasms in Patients With High-grade Ovarian Cancer Treated With Rucaparib 6
Advanced vulvar carcinoma: Is it worth operating? A perioperative management protocol for radical and reconstructive surgery 6
Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer The Multicenter Intergroup Study DESKTOP II. A Project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO 6
A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: A pilot study 6
Efficacy of adjuvant chemotherapy in early stage uterine leiomyosarcoma: A systematic review and meta-analysis 5
Gemcitabine (GEM) and liposomal doxorubicin (PLO) in recurrent/metastatic breast carcinoma: A phase II study 5
Artificial intelligence estimates the impact of human papillomavirus types in influencing the risk of cervical dysplasia recurrence: progress toward a more personalized approach 5
Role of pegylated liposomal doxorubicin (PLD) in epithelial ovarian cancer 5
Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: Association with pathological response to treatment and clinical outcome 5
28. Fucà G, Hindi N, Ray-Coquard I, Colia V, Dei Tos AP, Martin-Broto J, Brahmi M, Collini P, Lorusso D, Raspagliesi F, Pantaleo MA, Vincenzi B, Fumagalli E, Gronchi A, Casali PG, Sanfilippo R 5
Advances in laparoscopic surgery for cervical cancer 5
Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancer 5
Tumori dell'ovaio 5
Safety and effectiveness of Human Papillomavirus (HPV) vaccination: NCI of Milan position statement 5
Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS) 5
[Clinical applications of bevacizumab in the treatment of colorectal and ovarian cancer.] 5
3D vision improves outcomes in early cervical cancer treated with laparoscopic type B radical hysterectomy and pelvic lymphadenectomy 5
Chemotherapy in endometrial cancer. 5
High-Risk Borderline Ovarian Tumors: Analysis of Clinicopathological Features and Prognostic Impact of Different Follow-Up Strategies 5
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms 5
A critical assessment on the role of sentinel node mapping in endometrial cancer 5
Extraperitoneal Robotic-Assisted Para-Aortic Lymphadenectomy in Gynecologic Cancer Staging: Current Evidence 5
Newly diagnosed ovarian cancer: Which first-line treatment? 5
Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial 4
Gemcitabine in epithelial ovarian cancer treatment: current role and future perspectives 4
Invasive Paget Disease of the Vulva. 4
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study 4
Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change? 4
Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV) 4
Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis 4
Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: Updated results and long-term survival 4
Gynecologic Cancer Intergroup (GCIG) Consensus Review for Ovarian Germ Cell Tumors 4
Tailoring adjuvant treatment in patients with uterine cancer 4
CASE CONTROL STUDY ON TWO DIFFERENT CHEMOTHERAPY REGIMENS IN ADVANCED MIXED MULLERIAN TUMOURS 4
Gut microbiota and its influence on ovarian cancer carcinogenesis, anticancer therapy and surgical treatment: A literature review 4
Long-term safety of fertility sparing surgery in early stage ovarian cancer: Comparison to standard radical surgical procedures 4
Progress in the management of endometrial cancer (subtypes, immunotherapy, alterations in PIK3CA pathway): data and perspectives 4
Il carcinoma dell'ovaio 4
Tumori dell'apparato genitale femminile 4
Atypical Uterine Smooth Muscle Tumors: A Retrospective Evaluation of Clinical and Pathologic Features 4
Surgical Efforts Might Mitigate Difference in Response to Neoadjuvant Chemotherapy in Stage IIIC-IV Unresectable Ovarian Cancer: A Case-Control Multi-institutional Study 4
Sentinel Node Mapping Using Hysteroscopic Injection of Indocyanine Green and Laparoscopic Near-Infrared Fluorescence Imaging in Endometrial Cancer Staging 4
Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study 4
The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment 4
Investigating the Role of Minimally Invasive Radical Hysterectomy in Cervical Cancer 4
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study 4
Trophoblastic Disease Review for Diagnosis and Management A Joint Report From the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroup 4
Phase II Study of NGR-hTNF Plus Doxorubicin in Relapsed Ovarian Cancer (OC) 4
Review role of topotecan in gynaecological cancers: Current indications and perspectives 4
Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR/ENGOT-ov7 Randomized Clinical Trial 4
RECIST 1.1 criteria predict recurrence-free survival in advanced ovarian cancer submitted to neoadjuvant chemotherapy 4
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer - A Multicentre Italian Trial in Ovarian cancer (MITO-5) study 4
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial 4
Multicentre Italian Trials in Ovarian cancer (MITO) translational group. Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study 4
Pneumoperitoneum pressures during pelvic laparoscopic surgery: a systematic review and meta-analysis 4
Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment 4
Outcome and Risk Factors for Recurrence in Malignant Ovarian Germ Cell Tumors A MITO-9 Retrospective Study 4
Prospective validation of a predictive score for complete tumor resection in recurrent ovarian cancer (ROC): an intergroup study of AGO kommission OVAR, AGO-OVAR, AGO Austria, MITO and NOGGO 4
Laparoscopic Sentinel Node Mapping in Endometrial Cancer After Hysteroscopic Injection of Indocyanine Green 4
Sentinel node mapping in endometrial cancer following Hysteroscopic injection of tracers: A single center evaluation over 200 cases 4
Minimally invasive surgery improves short-term outcomes of nerve-sparing radical hysterectomy in patients with cervical cancer: a propensity-matched analysis with open abdominal surgery 4
Surgical Management and Prognostic Factors of Vulvovaginal Melanoma 4
"Tumori della vulva e della vagina" 4
The role of niraparib in the treatment of ovarian cancer: actuality and perspectives 4
Refining Adjuvant Therapy for Endometrial Cancer: New Standards and Perspectives 4
Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety 4
The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC-IV Unresectable Ovarian Cancer: Results From a Multi-Institutional Study 4
Sonographic imaging of urinoma 4
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome 4
Neoadjuvant chemotherapy followed by interval debulking surgery for unresectable stage IVB Serous endometrial cancer 4
Topotecan and gemcitabine in platinum/paclitaxel-resistant ovarian cancer 4
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy 4
Survival with Cemiplimab in Recurrent Cervical Cancer 4
Locally Advanced Cervical Cancer: Is a Trimodality Treatment a Safe and Effective Approach? 4
The detrimental effect of adopting interval debulking surgery in advanced stage low-grade serous ovarian cancer 4
Totale 547
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.329
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024854 0 0 0 0 0 0 0 0 271 18 179 386
2024/2025188 80 108 0 0 0 0 0 0 0 0 0 0
Totale 1.042